Vycor Medical, Inc. VYCO
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -60.00K | -13.80K | -72.50K | -16.50K | -81.20K |
| Total Depreciation and Amortization | 62.10K | 62.70K | 63.10K | 63.90K | 63.70K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 24.90K | 43.30K | 52.20K | 70.30K | 60.00K |
| Change in Net Operating Assets | 34.50K | 20.70K | -56.30K | -208.60K | -50.50K |
| Cash from Operations | 61.40K | 112.80K | -13.50K | -91.00K | -8.10K |
| Capital Expenditure | -1.60K | -5.20K | -5.20K | -3.60K | -9.00K |
| Sale of Property, Plant, and Equipment | 2.40K | 2.90K | 800.00 | 1.00K | 1.30K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 800.00 | -2.30K | -4.40K | -2.60K | -7.60K |
| Total Debt Issued | 59.00K | 59.00K | 59.00K | 59.00K | 61.00K |
| Total Debt Repaid | -62.10K | -57.10K | -59.90K | -58.90K | -64.90K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -3.00K | 2.00K | -800.00 | 200.00 | -3.90K |
| Foreign Exchange rate Adjustments | 0.00 | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 59.30K | 112.70K | -18.60K | -93.40K | -19.60K |